Realheart is a public company listed on Nasdaq First North Growth Market since December 17 2021, under the name (HEART).
👉🏿 During the period January 2 – 31 you can subscribe to #HEART TO2.
The established subscription price is SEK 8.47. The exercise period for the warrants began on January 2, 2025 and runs until January 31, 2025. The last day of trading in the warrants is January 29, 2025.
The Swedish innovation tradition has provided the world with medical technological inventions such as the heart and lung machine, the pacemaker and the dialysis machine. The next great innovation is Realheart’s artificial heart, Realheart TAH, a Swedish invention that not only saves lives but also creates a better quality of a prolonged life.